Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Divarasib |
Trade Name | |
Synonyms | GDC-6036|GDC6036|GDC 6036 |
Drug Descriptions |
Divarasib (GDC-6036) is a selective inhibitor of KRAS G12C that blocks downstream signaling, and may lead to anti-tumor activity (PMID: 37611121). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | 2417987-45-0 |
NCIT ID | C173995 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Divarasib | Atezolizumab Divarasib | 0 | 1 |
Bevacizumab + Divarasib | Bevacizumab Divarasib | 0 | 1 |
Cetuximab + Divarasib | Cetuximab Divarasib | 0 | 1 |
Divarasib | Divarasib | 0 | 4 |
Divarasib + Erlotinib | Divarasib Erlotinib | 0 | 1 |
Divarasib + GDC-1971 | Divarasib GDC-1971 | 0 | 0 |
Divarasib + Pembrolizumab | Divarasib Pembrolizumab | 0 | 1 |